title: Cardiovascular risk assessment and lipid modification: NICE guideline.
authors.affiliation: Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor.
authors.forename: Martin
authors.initials: M
authors.lastname: Duerden
authors.affiliation: National Clinical Guideline Centre for Acute and Chronic Conditions, Royal College of Physicians, London.
authors.forename: Norma
authors.initials: N
authors.lastname: O'Flynn
authors.affiliation: University of Nottingham, Nottingham.
authors.forename: Nadeem
authors.initials: N
authors.lastname: Qureshi
mesh_terms: D002318:Cardiovascular Diseases / Q000097:blood / Q000453:epidemiology / Q000517:prevention & control; D014943:Global Health; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood*; D009017:Morbidity / Q000639:trends; D017410:Practice Guidelines as Topic; D011322:Primary Prevention / Q000379:methods*; D018570:Risk Assessment / Q000592:standards*; D012307:Risk Factors
chemical_list: D000960:Hypolipidemic Agents; D008055:Lipids